Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,132 Diabetes
clinical trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Monmouth Cardiology Associates, LLC
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of America-NC, LLC
mi
from
Hickory, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
VA Medical Center Indianapolis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Metro Knoxville HMA
mi
from
Knoxville, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Main Street Physician's Care - Waterway
mi
from
Little River, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Finlay Medical Research, Corporation
mi
from
Miami, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ocala Research Institute, Inc
mi
from
Ocala, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
DBC Research, Corp
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
HealthEast Medical Research Institute
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Professional Health Care of Pinellas
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Heart Group of the Eastern Shore
mi
from
Fairhope, AL
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Chicago Medical Research, LLC
mi
from
Hazel Crest, IL
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Allegheny Health Network Research Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Animas Foot and Ankle
mi
from
Durango, CO
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Foot and Ankle
mi
from
Murray, UT
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Clinovation Research
mi
from
Weston, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolinas Healthcare-Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Peak Gastroenterology Associates
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Top Medical Research, Inc.
mi
from
Cutler Bay, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Verity Research
mi
from
Fairfax, VA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Amir Ali Hassan, MD, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Nepean Hospital
mi
from
Kingswood,
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Specialists
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Cfagi Llc
mi
from
Maitland, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Savin Medical Group LLC
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
SAGACT PLLC., San Antonio Gastroenterology Associates, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Del Sol Research Management
mi
from
Tucson, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers
Status: Enrolling
Updated: 10/11/2017
Foot & Ankle Physicians of Ohio
mi
from
Grove City, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rocky Mountain Regional VA Medical Center, Aurora, CO
mi
from
Aurora, CO
Click here to add this to my saved trials
Endocrinology, Other Clinical Trial
A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes
Status: Enrolling, Phase III
Updated: 10/11/2017
University of New Mexico Clincal & Translational Science Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers
Status: Enrolling, Phase III
Updated: 12/31/1969
NEA Baptist
mi
from
Jonesboro, AR
Click here to add this to my saved trials
T2DM With Inadequate Glycemic Control Clinical Trial
CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaohsiung Veterans General Hospital
mi
from
Kaohsiung,
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
Consano Clinical Research
mi
from
Shavano Park, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
Carolina Research Center at Jones Family Practice
mi
from
Shelby, NC
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification
Status: Enrolling
Updated: 10/24/2017
Dept. of Psychiatry and Neurobehavioral Sciences, University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Evaluation of TTP399 in Patients With Type 1 Diabetes
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Evaluation of TTP399 in Patients With Type 1 Diabetes
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Evaluation of TTP399 in Patients With Type 1 Diabetes
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Pancreatic Neoplasms Clinical Trial
A Pancreatic Cancer Screening Study in High Risk Individuals Including Those With New-Onset Diabetes Mellitus
Status: Enrolling, Phase
Updated: 12/31/1969
New Milford Hospital
mi
from
New Milford, CT
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado School of Medicine/Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Research Center of Miami II, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
The Impact of Diabetes on REvascularization
Status: Enrolling, Phase
Updated: 12/31/1969
Tampa VA
mi
from
Tampa, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
The Impact of Diabetes on REvascularization
Status: Enrolling, Phase
Updated: 12/31/1969
St. Boniface General Hospital
mi
from
Winnipeg,
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Buenos Aires,
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Type1 Diabetes Mellitus Clinical Trial
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
Status: Enrolling, Phase
Updated: 12/31/1969
Royal Devon & Exeter NHS Foundation Trust
mi
from
Exeter,
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Diabetes and Endocrinology, P.A. - South Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Florida Endocrine and Diabetes Consultants - Maitland
mi
from
Maitland, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
CMR of Greater New Haven, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
The Rose Salter Medical Research Foundation
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Diabetes & Endocrinology - Round Rock
mi
from
Round Rock, TX
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling, Phase III
Updated: 12/31/1969
Iowa Diabetes and Endocrinology Research Center
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indiana, PA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lorain, OH
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sheffield, AL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Smithtown, NY
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Waterbury, CT
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigational Site Number 8400001
mi
from
Bridgeton, NJ
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burlington, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Carrollton, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigational Site Number 8403033
mi
from
Hatboro, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Van Nuys, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Alan M Jacobs and Associates
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Biocon Clinical Research, LLC
mi
from
Caro, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley View Wellness and Medical Center - VVCRD Clinical Research
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates
mi
from
Greenville, SC
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Rodriguez Clinical Trials
mi
from
Houston, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research of South Nevada - CROSN
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Angel City Research Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Alabama Medical Group, P.C.
mi
from
Mobile, AL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology of Southern Indiana
mi
from
New Albany, IN
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington Gastroenterology, PLLC
mi
from
Tacoma, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Upland Clinical Research
mi
from
Upland, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
New Hope Research Development
mi
from
Whittier, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Cardinal Internal Medicine
mi
from
Woodbridge, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Aa Mrc Llc
mi
from
Flint, MI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Rockwood Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling, Phase II
Updated: 12/31/1969
Riverside Nephrology Physicians, Inc.
mi
from
Riverside, CA
Click here to add this to my saved trials
1 … 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 … 41